Alphatec reports prelim 2024 rev ~$611M (+27% YoY); guides 2025 rev $732M, positive FCF

Alphatec Holdings, Inc.

2024-FY EPS reported -$1.13 revenue$611,562,000

Preliminary full-year 2024 total revenue ~$611M (+27% YoY); surgical revenue up 29% to ~$544M.
Year-end 2024 cash ~$139M, up $58M from Q3, inclusive of $50M from term loan expansion.
2025 guidance: total revenue $732M (+20%), surgical $657M, EOS $75M; adjusted EBITDA ~$75M; positive FCF.
Issued 26,013 RSUs as inducement awards to 12 new non-executive employees.
Final Q4/FY2024 results scheduled for release on February 26, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.